跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Telvost
Approved
STANDARD
Telvost
XL Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
71f50a9a30930971
Company
XL Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
71f50a9a30930971
Drug Approval Philippines Name
Telvost
Product Name
Telvost
Registration Number
DRP-6519-02
Brand Name
Telvost
Generic Name
Montelukast (as sodium) + Levocetirizine (as dihydrochloride)
Dosage Form
Tablet
Dosage Strength
10 mg/5 mg
Manufacturer
XL Laboratories Pvt. Ltd
Importer
Ambica International Corporation
Distributor
Pharmasilv Trading
Issuance Date
24 October 2022
Expiry Date
18 April 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
71f50a9a30930971
Type
Standard
Back to Philippines FDA Approvals
Telvost - Philippines FDA Drug Approval Details